India among 20 countries interested in obtaining Covid-19 vaccine from Russia
RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines, and start mass production in other countries in partnership with local sovereign wealth funds, including India, (...)
Site référencé: The Economic Times
The Economic Times
Adani Green Q4 Results : Consolidated PAT plunges 70% YoY to Rs 150 crore
3/05/2024
Coforge’s Cigniti acquisition a game-changer, will be EPS accretive from day one, says CEO Sudhir Singh
3/05/2024
UK by-election : Labour wins as Tory PM Rishi Sunak stares at more losses
3/05/2024
Coforge shares crash 10% as Jefferies halves target price following Q4 miss
3/05/2024
8 small, midcap ideas by Axis Securities with up to 34% upside
3/05/2024
Are retail investors winning the battle against FIIs ? These 28 multibagger stocks show the trend
3/05/2024
